K982166 is an FDA 510(k) clearance for the CYTO-STAT TRICHROME CD45-FITC/CD56-RD1/CD3-PC5 MONOCLONAL ANTIBODY REAGENT WITH CYTO-STAT TRICHROME CD45-FITC/MSIGG1-RD1. This device is classified as a Counter, Differential Cell (Class II - Special Controls, product code GKZ).
Submitted by Coulter Corp. (Miami, US). The FDA issued a Cleared decision on November 5, 1998, 139 days after receiving the submission on June 19, 1998.
This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.5220.